Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Methylglyoxal
100%
Survival Potential
100%
Damage Effect
100%
Divergent Effects
100%
Mitochondrial Dysfunction
100%
Oxidative Stress
100%
HIV-1 Reverse Transcriptase
100%
Rilpivirine
100%
Pancreatic β-cell Function
100%
Type 2 Diabetes Mellitus (T2DM)
83%
Efavirenz
83%
Hepatic Complications
66%
Hepatic Disease
66%
Diabetic
66%
Hyperglycemia
66%
Nucleosides
50%
INS-1E Cells
50%
Reverse Transcriptase Inhibitors
50%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
50%
Therapeutic Adjuvant
33%
Type 2 Diabetes Complications
33%
Physiological Model
33%
Osmotic Stress
33%
Underlying Pathology
33%
Incomplete Knowledge
33%
Adjuvant Therapy
33%
Diabetes Incidence
33%
Hepatocytes
33%
Renal System
33%
Diabetes Complications
33%
University of Brighton
33%
Dicarbonyl Stress
33%
Glucose Metabolite
33%
Intracellular Concentration
33%
Hepatocyte Function
33%
Vascular System
33%
World Population
33%
Clinical Application
33%
Doravirine
33%
Emtricitabine
33%
Tenofovir Disoproxil Fumarate
33%
β-Cell Survival
33%
β-cell Function
33%
Insulin Requirement
33%
Cell Viability
33%
Type 2 Diabetic
33%
Apoptosis/necrosis
16%
Antiretroviral Therapy
16%
Glucose-regulated Protein 78 (GRP78)
16%
Oxidative Stress Toxicity
16%
Pharmacology, Toxicology and Pharmaceutical Science
Rilpivirine
100%
RNA Directed DNA Polymerase Inhibitor
100%
Reverse Transcriptase
100%
Efavirenz
83%
Maturity Onset Diabetes of the Young
66%
Insulin
50%
Nonnucleoside Reverse Transcriptase Inhibitor
50%
Nucleoside
50%
Doravirine
33%
Tenofovir Disoproxil
33%
Cell Viability
33%
Emtricitabine
33%
HIV
33%
Diabetes Mellitus
33%
Pathogenesis
16%
Messenger RNA
16%
Acquired Immune Deficiency Syndrome
16%
Necrosis
16%
Adenosine Triphosphate
16%
Mitochondrial Toxicity
16%
Synthetase
16%
Rat
16%
Insulinoma
16%
Medicine and Dentistry
Methylglyoxal
100%
Maturity Onset Diabetes of the Young
66%
Diabetes Mellitus
66%
Hyperglycemia
66%
Liver Disease
66%
Metabolite
66%
Adjuvant
33%
Osmotic Stress
33%
Renal System
33%
Liver Function
33%
Vascular System
33%
In Vitro
33%
Mediator
33%
Complications of Diabetes Mellitus
33%
Diabetes
33%
Adjuvant Therapy
33%
Hepatocyte
33%
Glucose
33%
